TY - JOUR AU - Gabarron, Elia AU - Årsand, Eirik AU - Wynn, Rolf PY - 2018da - 2018/08/10 TI -社交媒体在糖尿病干预中的应用:快速基于证据的综述JO - J Med Internet Res SP - e10303 VL - 20is - 8kw -社交媒体KW -社交网络KW -健康促进KW -干预研究KW -糖尿病AB -背景:卫生当局建议对糖尿病患者及其家属进行教育，并采取措施改善自我管理，促进积极的行为改变，降低并发症的风险。社交媒体可以为糖尿病教育的介入和传递提供有效的渠道。然而，目前尚不清楚在此类干预中使用这些通道是否有助于改善患者的预后。目的:我们研究的目的是回顾和描述目前关于在针对糖尿病患者的干预措施中使用社交媒体的现有证据。方法:检索4个数据库(PubMed、Scopus、EMBASE和Cochrane Library)。纳入的初步研究的证据质量根据推荐评价分级、发展和评价标准进行分级，系统评价的偏倚风险采用AMSTAR(评估系统评价的测量工具)指南进行评估。对这些研究报告的结果进行提取和分析。结果:我们纳入了20项中等和高质量的研究:17项初步研究和3项系统综述。在评估使用社交媒体干预对糖化血红蛋白(HbA1c)影响的16篇出版物中，13篇报道了HbA1c值的显著降低。 The 5 studies that measured satisfaction with the interventions using social media found positive effects. We found mixed evidence regarding the effect of interventions using social media on health-related quality of life (2 publications found positive effects and 3 found no differences) and on diabetes knowledge or empowerment (2 studies reported improvements and 2 reported no significant changes). Conclusions: There is very little good-quality evidence on the use of social media in interventions aimed at helping people with diabetes. However, the use of these channels is mostly linked to benefits on patients’ outcomes. Public health institutions, clinicians, and other stakeholders who aim at improving the knowledge of diabetic patients could consider the use of social media in their interventions. SN - 1438-8871 UR - //www.mybigtv.com/2018/8/e10303/ UR - https://doi.org/10.2196/10303 UR - http://www.ncbi.nlm.nih.gov/pubmed/30097421 DO - 10.2196/10303 ID - info:doi/10.2196/10303 ER -